Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Omission of Venetoclax Ramp-up Dosing during Induction Therapy for Acute Myeloid Leukemia in Combination with DNA Hypomethylating Agents Is Safe and Well-Tolerated

Brian Parkin, Caralyn Escobar, Roma Patel, Tori Smith, Amy Browning, Philip A. Pancari, Arlene A. Gayle, Shahram Mori

Blood (2024) 144 (Supplement 1): 4241.

https://doi.org/10.1182/blood-2024-210960

Published: 2024

Journal Articles

Phase II Study of Tagraxofusp in Newly Diagnosed Secondary Acute Myeloid Leukemia (S-AML) after Previous Exposure to Hypomethylating Agents (TAGALONG Study)

Steven D. Green, Brian Parkin, Catherine Lai, Ivana Gojo, Matthew C. Foster, Joshua F. Zeidner

Blood (2022) 140 (Supplement 1): 11749–11750.

https://doi.org/10.1182/blood-2022-170738

Published: 2022

Journal Articles

Updated Analyses: Safety and Efficacy of Gemtuzumab Ozogamicin and Venetoclax in Patients with Relapsed or Refractory CD33+ Acute Myeloid Leukemia: A Phase Ib/II Study

Saad Arain, Ana Maria Avila, Sonia Christian, Pritesh Patel, Karen Sweiss, Brian Parkin, Santosh L. Saraf, Paul G. Rubinstein, Gregory S Calip, John G. Quigley

Blood (2022) 140 (Supplement 1): 11725–11726.

https://doi.org/10.1182/blood-2022-165615

Published: 2022

Journal Articles

Role of Aneuploidy in Transcriptional Regulation and Clinical Prognosis in Relapsed and/or Refractory Multiple Myeloma (RRMM)

Christopher T Su, MD, Liying Chen, MS, Jason Chen, MD, Brian Parkin, MD, Avery Polk, Malathi Kandarpa, PhD, Craig E. Cole, MD, Erica Campagnaro, MD, Josh Vo, PhD, Dan Robinson, PhD, Yi-Mi Wu, PhD, Moshe Talpaz, MD, Jennifer Yesil, MSc, Daniel Auclair, P. Leif Bergsagel, MD, Arul Chinnaiyan, MDPhD, Veerabhadran Baladandayuthapani, PhD, J Christine Ye, MDMSc

Blood (2020) 136 (Supplement 1): 45–46.

https://doi.org/10.1182/blood-2020-134558

Published: 2020

Journal Articles

Aneuploidy Is Associated with Inferior Survival in Relapsed Refractory Multiple Myeloma Patients

J Christine Ye, MDMSc, Liying Chen, Jason Chen, MD, Brian Parkin, Avery Polk, Malathi Kandarpa, PhD, Craig E. Cole, MD, Erica L. Campagnaro, MD, Dan Robinson, PhD, Yi-Mi Wu, Moshe Talpaz, MD, Jennifer Yesil, Daniel Auclair, P. Leif Bergsagel, MD, Arul Chinnaiyan, MD, Veerabhadran Baladandayuthapani

Blood (2019) 134 (Supplement_1): 4360.

https://doi.org/10.1182/blood-2019-124135

Published: 2019

Journal Articles

Rational Modification of Intestinal Microbiome and Metabolites after Allogeneic Hematopoietic Stem Cell Transplantation with Resistant Starch: A Pilot Study

Mary Mansour Riwes, DO, Alexander Schmidt, Thomas Braun, John M. Magenau, MD, Attaphol Pawarode, Brian Parkin, Sarah Anand, MD, Monalisa Ghosh, John Maciejewski, Darren King, Muneesh Tewari, Sung W. Choi, Gregory A. Yanik, Kristi Maccready, Thomas Schmidt, Pavan Reddy

Blood (2019) 134 (Supplement_1): 3276.

https://doi.org/10.1182/blood-2019-131216

Published: 2019

Journal Articles

Phase 2 Study of Pembrolizumab during Lymphodepleted State after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma Patients

Attaphol Pawarode, MD, Anita D'Souza, MBBS, Marcelo C. Pasquini, MD, Bryon Johnson, PhD, Thomas Braun, PhD, Binod Dhakal, MBBS, Mehdi Hamadani, MD, John M. Magenau, MD, Nirav N Shah, MD, Mary Mansour Riwes, DO, Brian Parkin, MD, Pavan Reddy, MD, Parameswaran Hari, MD MRCP, MS

Blood (2017) 130 (Supplement 1): 339.

https://doi.org/10.1182/blood.V130.Suppl_1.339.339

Published: 2017

Journal Articles

Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT

Sung Won Choi, Thomas Braun, Israel Henig, Erin Gatza, John Magenau, Brian Parkin, Attaphol Pawarode, Mary Riwes, Greg Yanik, Charles A. Dinarello, Pavan Reddy

Blood (2017) 130 (15): 1760–1767.

https://doi.org/10.1182/blood-2017-06-790469

Published: 2017

Journal Articles

High-Sensitivity Genomic Minimal Residual Disease Detection Reveals Multiclonal Hematopoiesis and Is Associated with Survival in Adult AML

Brian Parkin, Angelina Londoño Joshi, PhD, Qing Kang, PhD, Andrew D. Rhim, MD, Sami N. Malek

Blood (2015) 126 (23): 225.

https://doi.org/10.1182/blood.V126.23.225.225

Published: 2015

Journal Articles

The Impact of Diabetes on Clinical Outcomes in Chronic Lymphocytic Leukemia

Erlene Kuizon Seymour, Kamlai Saiya-Cork, Brian Parkin, Kerby Shedden, Jennifer Griggs, Sami N. Malek

Blood (2015) 126 (23): 2095.

https://doi.org/10.1182/blood.V126.23.2095.2095

Published: 2015

Journal Articles

Gene Mutations Identified in Chemorefractory Acute Myeloid Leukemia

Anthony Palmer, Brian Parkin, Hidde Posthuma, Shin Mineishi, MD, John M. Magenau, Sami N. Malek

Blood (2015) 126 (23): 3838.

https://doi.org/10.1182/blood.V126.23.3838.3838

Published: 2015

Journal Articles

Phase 1 Study of Carfilzomib for the Prevention of Relapse and Graft-Versus-Host Disease in Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

Attaphol Pawarode, MD, Steven Goldstein, MD, Daniel R. Couriel, MD, Thomas Braun, PhD, John M. Magenau, MD, Mary Mansour Riwes, DO, Brian Parkin, Vedran Radojcic, MD, David Frame, PharmD, Sung Choi, MD, James Connelly, MD, John E. Levine, MD MS, Gregory A. Yanik, MD, Pavan Reddy, MD

Blood (2015) 126 (23): 1907.

https://doi.org/10.1182/blood.V126.23.1907.1907

Published: 2015

Journal Articles

A Quantitative Analysis of Subclonal and Clonal Gene Mutations Occurring Pre- and Post-Therapy in 53 Cases of Chronic Lymphocytic Leukemia

Nisar A. Amin, Erlene Kuizon Seymour, Peter Ulintz, Kamlai Saiya-Cork, Brian Parkin, Kerby Shedden, Sami N. Malek

Blood (2015) 126 (23): 2909.

https://doi.org/10.1182/blood.V126.23.2909.2909

Published: 2015

Journal Articles

Activating STAT6 mutations in follicular lymphoma

Mehmet Yildiz, Hongxiu Li, Denzil Bernard, Nisar A. Amin, Peter Ouillette, Siân Jones, Kamlai Saiya-Cork, Brian Parkin, Kathryn Jacobi, Kerby Shedden, Shaomeng Wang, Alfred E. Chang, Mark S. Kaminski, Sami N. Malek

Blood (2015) 125 (4): 668–679.

https://doi.org/10.1182/blood-2014-06-582650

Published: 2015

Includes: Supplemental data

Journal Articles

Genomic Complexity Versus Gene Mutations In Predicting Overall Survival In Adult Acute Myelogenous Leukemia

Brian Parkin, MD, Peter Ouillette, Mehmet Yildiz, MD, Kamlai Saiya-Cork, Kerby Shedden, PhD, Sami Malek, MD

Blood (2013) 122 (21): 1324.

https://doi.org/10.1182/blood.V122.21.1324.1324

Published: 2013

Journal Articles

Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemia

Brian Parkin, Peter Ouillette, Yifeng Li, Jennifer Keller, Cindy Lam, Diane Roulston, Cheng Li, Kerby Shedden, Sami N. Malek

Blood (2013) 121 (2): 369–377.

https://doi.org/10.1182/blood-2012-04-427039

Published: 2013

Includes: Supplemental data

Journal Articles

Clonal Evolution and Devolution Following Chemotherapy in Adult Acute Myelogenous Leukemia.

Brian Parkin, MD, Peter Ouillette, Yifeng Li, PhD, Cheng Li, PhD, Kerby Shedden, PhD, Sami Malek, MD

Blood (2012) 120 (21): 2487.

https://doi.org/10.1182/blood.V120.21.2487.2487

Published: 2012

Journal Articles

Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia

Brian Parkin, Harry Erba, Peter Ouillette, Diane Roulston, Anjali Purkayastha, Judith Karp, Moshe Talpaz, Lisa Kujawski, Sajid Shakhan, Cheng Li, Kerby Shedden, Sami N. Malek

Blood (2010) 116 (23): 4958–4967.

https://doi.org/10.1182/blood-2010-01-266999

Published: 2010

Includes: Supplemental data

Journal Articles

Acquired Genomic Copy Number Aberrations and Survival In CLL

Sami Malek, MD, Brian Parkin, MD, Edward M. Peres, MD, Moshe Talpaz, MD, Mark S. Kaminski, MD, Lisa Kujawski, MD, Roxanne Collins, Kerby Shedden, Peter Ouillette

Blood (2010) 116 (21): 1713.

https://doi.org/10.1182/blood.V116.21.1713.1713

Published: 2010

Journal Articles

The Prognostic Importance of Various 13q14 Deletions In CLL

Sami Malek, MD, Brian Parkin, MD, Roxanne Collins, Kerby Shedden, Peter Ouillette

Blood (2010) 116 (21): 3587.

https://doi.org/10.1182/blood.V116.21.3587.3587

Published: 2010

NARROW

Omission of Venetoclax Ramp-up Dosing during Induction Therapy for Acute Myeloid Leukemia in Combination with DNA Hypomethylating Agents Is Safe and Well-Tolerated

Phase II Study of Tagraxofusp in Newly Diagnosed Secondary Acute Myeloid Leukemia (S-AML) after Previous Exposure to Hypomethylating Agents (TAGALONG Study)

Updated Analyses: Safety and Efficacy of Gemtuzumab Ozogamicin and Venetoclax in Patients with Relapsed or Refractory CD33+ Acute Myeloid Leukemia: A Phase Ib/II Study

Role of Aneuploidy in Transcriptional Regulation and Clinical Prognosis in Relapsed and/or Refractory Multiple Myeloma (RRMM)

Aneuploidy Is Associated with Inferior Survival in Relapsed Refractory Multiple Myeloma Patients

Rational Modification of Intestinal Microbiome and Metabolites after Allogeneic Hematopoietic Stem Cell Transplantation with Resistant Starch: A Pilot Study

Phase 2 Study of Pembrolizumab during Lymphodepleted State after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma Patients

Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT

High-Sensitivity Genomic Minimal Residual Disease Detection Reveals Multiclonal Hematopoiesis and Is Associated with Survival in Adult AML

The Impact of Diabetes on Clinical Outcomes in Chronic Lymphocytic Leukemia

Gene Mutations Identified in Chemorefractory Acute Myeloid Leukemia

Phase 1 Study of Carfilzomib for the Prevention of Relapse and Graft-Versus-Host Disease in Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

A Quantitative Analysis of Subclonal and Clonal Gene Mutations Occurring Pre- and Post-Therapy in 53 Cases of Chronic Lymphocytic Leukemia

Activating STAT6 mutations in follicular lymphoma

Genomic Complexity Versus Gene Mutations In Predicting Overall Survival In Adult Acute Myelogenous Leukemia

Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemia

Clonal Evolution and Devolution Following Chemotherapy in Adult Acute Myelogenous Leukemia.

Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia

Acquired Genomic Copy Number Aberrations and Survival In CLL

The Prognostic Importance of Various 13q14 Deletions In CLL

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only